Integrated RPA-CRISPR/Cas12a system towards Point-of-Care H. pylori detection
Integrated RPA-CRISPR/Cas12a system towards Point-of-Care H. pylori detection
The rapidly advanced CRISPR/Cas biosensing technology provides unprecedent potential for the development of novel biosensing systems. It provides a new approach for realizing rapid, sensitivity and highly specific pathogen nucleic acid detection, with the capability to combine other technologies, including Polymerase Chain Reaction or isothermal amplifications. The detection of Helicobacter pylori (H. pylori), one of the most common human pathogens to cause various gastroduodenal diseases, has also been explored with the assistance of CRISPR/Cas systems. However, gaps still remain for the development of end-user friendly sensing systems.In this study, a combined RPA-CRISPR/Cas12a biosensing system has been established. It shown the capability to quantitively detect the presence of H. pylori genome DNA with 4 orders of magnitude linear range, and sensitivity of 1.4 copies/μL. The overall reaction can be done within 45 mins at room temperature, which eliminates the needs for heating instrumentation. In addition, with the addition of pullulan as a protective reagent, the potential of storing CRISPR/Cas12a system reagents by using a freeze-dry approach has also been demonstrated.Clinical Relevance-This study represents a novel exploration to applying CRISPR/Cas12a-based biosensing technology to the detection of pathogen DNA with improved potential for the development of Point-of-Care diagnostics. This critical aspect of our technology will contribute to address the newly emerged pathogenic threats and support public health systems.
Deng, Fei
426fa10e-62cf-4593-b476-160aa39a8ece
Zhang, Chengchen
abc47c06-4b99-4aed-be72-463f211e9dfa
Goldys, Ewa
9f624161-efbc-4549-970c-ba5d9e3ba0e9
24 July 2023
Deng, Fei
426fa10e-62cf-4593-b476-160aa39a8ece
Zhang, Chengchen
abc47c06-4b99-4aed-be72-463f211e9dfa
Goldys, Ewa
9f624161-efbc-4549-970c-ba5d9e3ba0e9
Deng, Fei, Zhang, Chengchen and Goldys, Ewa
(2023)
Integrated RPA-CRISPR/Cas12a system towards Point-of-Care H. pylori detection.
In 2023 45th Annual International Conference of the IEEE Engineering in Medicine and Biology Conference, EMBC 2023 - Proceedings.
IEEE..
(doi:10.1109/EMBC40787.2023.10340749).
Record type:
Conference or Workshop Item
(Paper)
Abstract
The rapidly advanced CRISPR/Cas biosensing technology provides unprecedent potential for the development of novel biosensing systems. It provides a new approach for realizing rapid, sensitivity and highly specific pathogen nucleic acid detection, with the capability to combine other technologies, including Polymerase Chain Reaction or isothermal amplifications. The detection of Helicobacter pylori (H. pylori), one of the most common human pathogens to cause various gastroduodenal diseases, has also been explored with the assistance of CRISPR/Cas systems. However, gaps still remain for the development of end-user friendly sensing systems.In this study, a combined RPA-CRISPR/Cas12a biosensing system has been established. It shown the capability to quantitively detect the presence of H. pylori genome DNA with 4 orders of magnitude linear range, and sensitivity of 1.4 copies/μL. The overall reaction can be done within 45 mins at room temperature, which eliminates the needs for heating instrumentation. In addition, with the addition of pullulan as a protective reagent, the potential of storing CRISPR/Cas12a system reagents by using a freeze-dry approach has also been demonstrated.Clinical Relevance-This study represents a novel exploration to applying CRISPR/Cas12a-based biosensing technology to the detection of pathogen DNA with improved potential for the development of Point-of-Care diagnostics. This critical aspect of our technology will contribute to address the newly emerged pathogenic threats and support public health systems.
This record has no associated files available for download.
More information
Published date: 24 July 2023
Additional Information:
Publisher Copyright:
© 2023 IEEE.
Venue - Dates:
45th Annual International Conference of the IEEE Engineering in Medicine and Biology Conference, EMBC 2023, , Sydney, Australia, 2023-07-24 - 2023-07-27
Identifiers
Local EPrints ID: 492353
URI: http://eprints.soton.ac.uk/id/eprint/492353
ISSN: 1557-170X
PURE UUID: 827ff05d-8b62-4e9d-bdee-0510800596e8
Catalogue record
Date deposited: 24 Jul 2024 17:05
Last modified: 27 Jul 2024 02:10
Export record
Altmetrics
Contributors
Author:
Fei Deng
Author:
Chengchen Zhang
Author:
Ewa Goldys
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics